Renaissance Technologies’s Entera Bio ENTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ENTX
SL
SEIA
VF
GIA
Renaissance Technologies's ENTX Position: Q2 2026 in Review
Renaissance Technologies reduced its Entera Bio (ENTX) stake by 22% in Q2 2026, selling an estimated $131K and leaving 368,847 shares worth $653K. The position accounts for ﹤0.01% of the portfolio, ranked #2500.
Renaissance Technologies first reported a position in ENTX in Q4 2020 and has held it in 19 quarters since. 15 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.
- Renaissance Technologies held 368,847 shares of Entera Bio worth $653K as of Q2 2026.
- Renaissance Technologies sold 104,595 Entera Bio shares in Q2 2026, an estimated $131K.
- Entera Bio made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2500 holding.
- Renaissance Technologies first reported a position in Entera Bio in Q4 2020 and has held it in 19 quarters since.
- 15 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.